Outlook Therapeutics OTLK
NASDAQ OTLK
$0.48 +0.02 (+4.43%)
At close: Nov 11, 2026 · 4:00 PM EST

Outlook Therapeutics (OTLK) Common Stock Issued (2015 - 2026)

Updated

Outlook Therapeutics (OTLK) recorded Common Stock Issued of $28.61 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 95.9% from $14.6 million a year earlier and up 314.6% from the prior quarter.

Analysis

Outlook Therapeutics (OTLK) Common Stock Issued (2015 - 2026) Analysis & Trends

On a TTM basis, Outlook Therapeutics' Common Stock Issued came in at $87.41 million as of Jun 30, 2026, up 153.5% year-over-year; for FY2025 (ended Sep 30, 2025), it was $70.05 million, up 16.1% from FY2024.

  • Annual Common Stock Issued has a five-year compound annual growth rate of 13.9% (FY2020 to FY2025).
  • Across earlier fiscal years, Common Stock Issued came in at $60.33 million in FY2024 (+101.0%), $30.02 million in FY2023 (-52.0%), $62.51 million in FY2022 (+25.3%) and $49.9 million in FY2021 (+36.4%).
  • Quarterly Common Stock Issued has ranged from -$339,275 in fiscal Q2 2023 to $57.67 million in fiscal Q1 2022 over the past five years.
  • On a year-over-year basis, Common Stock Issued rose in three of the last four quarters, with growth averaging 279.1%.
  • Peak year-over-year performance for Common Stock Issued in the last five years was growth of 843.6% in fiscal Q1 2026, against a decline of 89.3% in fiscal Q3 2022 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $6.9 million (Q2 2026), $16.44 million (Q1 2026) and $35.46 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 743.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 247.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 87.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Outlook Therapeutics 62.90 Mn 27.15 Mn -8,265.00 28.61 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 28.61 Mn
Mar 31, 2026 6.90 Mn
Dec 31, 2025 16.44 Mn
Sep 30, 2025 35.46 Mn
Jun 30, 2025 14.60 Mn
Mar 31, 2025 18.25 Mn
Dec 31, 2024 1.74 Mn
Sep 30, 2024 -114,954.00
Jun 30, 2024 4.31 Mn
Sep 30, 2023 2.43 Mn
Jun 30, 2023 3.30 Mn
Mar 31, 2023 -339,275.00
Dec 31, 2022 24.64 Mn
Sep 30, 2022 1.63 Mn
Jun 30, 2022 293,004.00
Mar 31, 2022 2.92 Mn
Dec 31, 2021 57.67 Mn
Sep 30, 2021 3.80 Mn
Jun 30, 2021 2.73 Mn
Sep 30, 2020 691,456.00
API Access

Outlook Therapeutics Common Stock Issued API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-stock-issued&ticker=OTLK&period=max&api_key=YOUR_API_KEY